title: Early molecular effects of ethanol during vertebrate embryogenesis.
abstract: Fetal alcohol spectrum disorder (FASD) is the combination of developmental, morphological, and neurological defects that result from exposing human embryos to ethanol (EtOH). Numerous embryonic structures are affected, leading to a complex viable phenotype affecting among others, the anterior/posterior axis, head, and eye formation. Recent studies have provided evidence suggesting that EtOH teratogenesis is mediated in part through a reduction in retinoic acid (RA) levels, targeting mainly the embryonic organizer (Spemann's organizer) and its subsequent functions. EtOH-treated Xenopus embryos were subjected to an analysis of gene expression patterns. Analysis of organizer-specific genes revealed a transient delay in the invagination of gsc- and chordin-positive cells that eventually reach their normal rostro-caudal position. Dorsal midline genes show defects along the rostro-caudal axis, lacking either their rostral (Xbra and Xnot2) or caudal (FoxA4b and Shh) expression domains. Head-specific markers like Otx2, en2, and Shh show abnormal expression patterns. Otx2 exhibits a reduction in expression levels, while en2 becomes restricted along the dorsal/ventral axis. During neurula stages, Shh becomes up-regulated in the rostral region and it is expressed in an abnormal pattern. These results and histological analysis suggest the existence of malformations in the brain region including a lack of the normal fore brain ventricle. An increase in the size of both the prechordal plate and the notochord was observed, while the spinal cord is narrower. The reduction in head and eye size was accompanied by changes in the eye markers, Pax6 and Tbx3. Our results provide evidence for the early molecular changes induced by EtOH exposure during embryogenesis, and may explain some of the structural changes that are part of the EtOH teratogenic phenotype also in FASD individuals.
authors.affiliation: Department of Cellular Biochemistry and Human Genetics, Faculty of Medicine, Hebrew University, Jerusalem 91120, Israel.
authors.forename: Ronit
authors.initials: R
authors.lastname: Yelin
authors.forename: Hadas
authors.initials: H
authors.lastname: Kot
authors.forename: Dvir
authors.initials: D
authors.lastname: Yelin
authors.forename: Abraham
authors.initials: A
authors.lastname: Fainsod
mesh_terms: D000818:Animals; D002492:Central Nervous System Depressants / Q000494:pharmacology*; D004625:Embryo, Nonmammalian / Q000187:drug effects*; D047108:Embryonic Development; D000431:Ethanol / Q000494:pharmacology*; D005260:Female; D063647:Fetal Alcohol Spectrum Disorders / Q000473:pathology; D005775:Gastrula / Q000187:drug effects / Q000502:physiology; D018507:Gene Expression Regulation, Developmental; D008850:Microphthalmos / Q000473:pathology; D023421:Models, Animal; D009024:Morphogenesis / Q000187:drug effects; D020897:Organizers, Embryonic / Q000187:drug effects*; D014212:Tretinoin / Q000378:metabolism; D029867:Xenopus Proteins / Q000378:metabolism; D014982:Xenopus laevis / Q000196:embryology*
chemical_list: D002492:Central Nervous System Depressants; D029867:Xenopus Proteins; D000431:Ethanol; D014212:Tretinoin